NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000055545

Registered date:25/10/2024

Determination of ED95 of remimazolam to achieve loss of consciousness during anesthesia induction in obesity patients

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedObese patient, ASA class I,II
Date of first enrollment2024/01/25
Target sample size40
Countries of recruitmentAsia(except Japan)
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeED95 of remimazolam
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum19years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaPatients allergic to benzodiazepines Patients who regularly use sleeping pills, benzodiazepines, opioids, or alcohol Patients with communication difficulties (ex. hearing impairment, dementia, etc.)

Related Information

Contact

public contact
Name Jiyoun Lee
Address 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi-do, South Korea 13620
Telephone +82317877499
E-mail heykiki1@hanmail.net
Affiliation Seoul national university Bundang hospital Anesthesiology and Pain medicine
scientific contact
Name In-Ae Song
Address 82 Gumi-ro, 173 Beon-gil, Bundang-gu, Seongnam, Gyeonggi-do, South Korea
Telephone +82317877499
E-mail sia1@snubh.org
Affiliation Seoul national university Bundang hospital Anesthesiology and Pain medicine